DaVita Inc.
21250 Hawthorne Boulevard, Suite 800
Torrance
California
90503
United States
Tel: 310-792-2600
Fax: 310-792-8928
Website: http://www.davita.com/
Email: lzumwalt@davita.com
232 articles about DaVita Inc.
-
DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2024
3/8/2024
DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at Barclays Global Healthcare Conference 2024 on Wednesday, March 13, 2024, at 8:00 a.m. EDT.
-
DaVita enters into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador
3/5/2024
DaVita Inc, a leading provider of kidney care services, announced that it has agreed to terms on the expansion of its international operations in Brazil and Colombia, and its entry into Chile and Ecuador.
-
DaVita Inc. to Participate in the TD Cowen's Health Care Conference 2024
2/29/2024
DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at TD Cowen's Health Care Conference 2024 on Monday, March 4, 2024, at 11:10 a.m. EST.
-
DaVita Inc. 3rd Quarter 2023 Results
11/7/2023
DaVita Inc. announced financial and operating results for the quarter ended September 30, 2023.
-
The first two weeks of October saw BMS’s $4.8 billion buyout of Mirati, Lilly’s $1.4 billion purchase of Point, Kyowa Kirin’s $387 million acquisition of Orchard and AbbVie’s $110 million Mitokinin deal.
-
Dialysis giant DaVita on Thursday raised concerns over Novo Nordisk’s interim analysis of a kidney outcomes study of semaglutide, pointing to the potentially limited applicability of the findings.
-
DaVita Inc. Schedules 2nd Quarter 2023 Investor Conference Call
7/13/2023
DaVita Inc., announced that it will hold its quarterly conference call to discuss second quarter results on Thursday, August 3rd, 2023, at 5:00 p.m. Eastern Time.
-
DaVita Announces Wendy Schoppert to Join its Board of Directors
7/13/2023
DaVita Inc. announced that its Board of Directors appointed a new independent director, Wendy Schoppert, to join the Board, effective as of July 14, 2023.
-
Medtronic, DaVita launch Mozarc Medical, aimed at introducing new solutions for patients with kidney failure
4/1/2023
Medtronic plc and DaVita Inc. announced the launch of Mozarc Medical—an independent new company committed to reshaping kidney health and driving patient-centered technology solutions.
-
DaVita Inc. to Participate in the Barclays 2023 Global Healthcare Conference
3/13/2023
DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the Barclays 2023 Global Healthcare Conference on Tuesday, March 14, 2023, at 3:05 p.m. EDT.
-
DaVita Inc. Schedules 4th Quarter 2022 Investor Conference Call
2/1/2023
DaVita Inc., announced that it will hold its quarterly conference call to discuss fourth quarter and full year results on Wednesday, February 22, 2023, at 5:00 p.m. Eastern Time.
-
DaVita Inc. 3rd Quarter 2022 Results
10/28/2022
DaVita Inc. announced financial and operating results for the quarter ended September 30, 2022.
-
DaVita Inc. Schedules 3rd Quarter 2022 Investor Conference Call
10/14/2022
DaVita Inc., announced that it will hold its quarterly conference call to discuss third quarter results on Friday, October 28, 2022, at 8:30 a.m. Eastern Time.
-
DaVita Announces Adam H. Schechter to Join its Board of Directors
9/13/2022
DaVita Inc. announced that its Board of Directors appointed a new independent director, Adam H. Schechter, to join the Board, effective September 20, 2022.
-
DaVita Inc. Schedules 2nd Quarter 2022 Investor Conference Call
7/18/2022
DaVita Inc., announced that it will hold its quarterly conference call to discuss second quarter results on Monday, August 1, 2022, at 5:00 p.m. Eastern Time.
-
Medtronic and DaVita announce new kidney health technology company
5/26/2022
Medtronic plc and DaVita Inc. announced the intent to form a new, independent kidney care-focused medical device company to enhance the patient treatment experience and improve overall outcomes.
-
DaVita Inc. to Participate in the Bank of America Securities 2022 Healthcare Conference
5/9/2022
DaVita Inc. announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the Bank of America Securities 2022 Healthcare Conference on Tuesday, May 10, 2022, at 11 a.m. EDT.
-
DaVita Inc. Schedules 1st Quarter 2022 Investor Conference Call
4/21/2022
DaVita Inc., announced that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 5, 2022, at 5 p.m. Eastern Time.
-
Rockwell Medical Expands Partnership with DaVita
4/11/2022
Rockwell Medical, Inc., a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, announced an expanded partnership with DaVita Inc., a leading kidney care provider.
-
DaVita Inc. 4th Quarter 2021 Results
2/10/2022
DaVita Inc. announced financial and operating results for the quarter and year ended December 31, 2021.